Effect of exogenous administration of transforming growth factor-beta and famotidine on the healing of duodenal ulcer under the impact of indomethacin

Digestive and Liver Disease

Volumn 35, Issue 6, 2003, Pages 397-403

  Pérez Aisa, Alanas ^a   Sopena F ^a   Arceiz, E ^a   Ortego, J ^a   Sainz, R ^a   Lanas, A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Duodenal ulcer; Famotidine; Indomethacin; TGF

Indexed keywords

COLLAGEN; FAMOTIDINE; INDOMETACIN; PLACEBO; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DUODENUM ULCER; EPITHELIUM CELL; GRANULATION TISSUE; HISTOPATHOLOGY; MALE; MICROSCOPE; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE; STOMACH SECRETION; ULCER HEALING; ANIMAL; PATHOLOGY; SECRETION; STOMACH ACID; WISTAR RAT;

ANIMALS; DUODENAL ULCER; FAMOTIDINE; GASTRIC ACID; INDOMETHACIN; MALE; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA;

EID: 0142125271     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00165-8     Document Type: Article

References (41)

1. Lanas A, Remacha B, Esteva F, Sainz R. Risk factors associated with refractory peptic ulcers. Gastroenterology 1995;109:1124-33.
2. Fiorucci S, Antonelli E, Morelli A. Mechanism of non-steroidal anti-inflammatory drug-gastropathy. Dig Liver Dis 2001;33(Suppl 2):S35-43.
3. Hudson N, Balsitis M, Hawkey CJ. Reduction in angiogenesis in non-steroidal anti-inflammatory drug associated gastric ulcers. Digestion 1991;49:19.
4. Konturek SJ, Brzozowski T, Majka J, Dembinski A, Slomiany A, Slomiany BL. Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury. Scand J Gastroenterol 1992;27:649-55.
5. Romano M, Lesch CA, Meise KS, Veljaca M, Sanchez B, Kraus ER, et al. Increased gastroduodenal concentrations of transforming growth factor α in adaptation to aspirin in monkeys and rats. Gastroenterology 1996;110:1446-55.
6. Romano M, Polk WH, Awad JA, Arteaga CL, Nanney LB, Wargovich MJ, et al. TGF-α protects against drug-induced injury to rat gastric mucosa in vivo. J Clin Invest 1992;90:2409-21.
7. Calabro A, Milani S, Paladini Y, Orsini B, Salvadori G, Surrenti C. Role of epidermal factor in peptic ulcer healing. Dig Dis Sci 1995;40:2497-504.
8. Ross R. Platelet derived growth factor. Lancet 1989;1:1179-82.
9. Lanas A, Haggerty P, Hirschowitz BI. In vitro studies of antiinflammatory agents and prostaglandin E2 effects on stimulated normal human fibroblast cultures. Inflammopharmacology 1994;2:377-87.
10. Gospodarowicz PHD. Fibroblast growth factor: chemical structure and biological function. Clin Orthop Relat Res 1990;257:231-48.
11. Mustoe TA, Landes A, Cromack DT, Mistry D, Griffin A, Deuel TF, et al. Differential acceleration of healing of surgical incisions in the rabbit gastrointestinal tract by platelet-derived growth factor and transforming growth factor, type beta. Surgery 1990;108:324-30.
12. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
13. Tarnaswki A, Stachura J, Douglass TG, Krause WJ, Gergley H, Sarfeh IJ. Indomethacin impairs quality of experimental gastric ulcer healing: a quantitative histological and ultrastructural analysis. In: Garner A, O'Brien P, editors, Mechanisms of injury, protection and repair of the upper gastrointestinal tract, New York: John Wiley, 1991, pp. 521-31.
14. Konturek SJ, Dembinski A, Warzecha Z, Brozozwski T, Gregory H. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1988;94:1300-7.
15. Diebold J, Dopfer K, Lai M, Lohrs U. Comparison of different monoclonal antibodies for the immunohistochemical assessment of cell proliferation in routine colorectal biopsy specimens. Scand J Gastroenterol 1994;29:47-53.
16. Lowry A, Wilcox D, Masson EA, Williams PE. Immunohistochemical methods for semiquantitative analysis of collagen content in human peripheral nerve. J Anat 1997;191:367-74.
17. NIH Image 6.1. http://rsb.info.nih.gov /nih-image/.
18. Lanas A, Hirschowitz BI. Influence of smoking on basal and on vagally and maximally stimulated gastric acid and pepsin secretion. Scand J Gastroenterol 1992;27:208-12.
19. Arceiz E, Lanas A, Ortego J, Sainz R. Platelet derived growth factor reverses the effects induced by NSAIDs on ulcer healing. Eur J Gastroenterol Hepatol 1997;9:1179-84.
20. McCarthy DM. Mechanisms of mucosal injury and healing: the role of nonsteroidal antiinflammatory drugs. Scand J Gastroenterol 1995;30(Suppl 208):24-9.
21. Schamassmann A. Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs. Am J Med 1998;104:43S-51S.
22. Lanas A, Hirschowitz BI. Ingestion of aspirin prevents platelet aggregation and impairs release of growth factors - implications for peptic ulcer healing. Scand J Gastroenterol 1994;29:17-22.
23. Hawkey CJ. Non-steroidal anti-inflammatory drugs gastropathy: causes and treatment. Scand J Gastroenterol Suppl 1996;220:124-7.
24. 1. Gut 1996;39:172-5.
25. Coerper S, Sigloch E, Cox M, Starlinger M, Koveker G, Becker HD. Recombinant human transforming growth factor β3 accelerates gastric ulcer healing in rats. Scand J Gastroenterol 1997;32:985-90.
26. Tominaga K, Arakawa T, Kim S, Hiroshi Y, Kobayashi K. Increased expression of transforming growth factor-β1 during gastric ulcer healing in rats. Dig Dis Sci 1997;42:616-25.
27. McAnulty R, Hernandez-Rodriguez N, Mutsaers S, Coker R, Laurent G. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-β isoforms on fibroblast cell cultures. Biochem J 1997;321:639-43.
28. Piazuelo E, Lanas A, Jimenez P, García-González A, Esteva F. In vitro wound repair by human gastric fibroblast. Implications for ulcer healing. Dig Dis Sci 1998;43:1230-40.
29. Bennett NT, Scultz S. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 1993;165:728-37.
30. Lanas A, Garcia Gonzalez A, Esteva F, Piazuelo E, Jimenez P, Morandeira JR. Collagen secretion by human gastric and skin fibroblasts: implications for ulcer healing. Eur Surg Res 1998;30:48-54.
31. Fritsch C, Simon-Assman P, Kedinger M, Evans G. Cytokines modulate fibroblast phenotype and epithelial-stroma interactions in rat intestine. Gastroenterology 1997;112:826-38.
32. Martens M, Huyben C, Hendriks T. Collagen synthesis in fibroblast from human colon: regulatory aspects and differences with skin fibroblast. Gut 1992;33:1664-70.
33. Hasan A, Murata H, Falabella A, Ochoa S, Zhou L, Badiavas E, et al. Dermal fibroblast from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. J Dermatol Sci 1997;16:59-66.
34. Hudson N, Taha A, Russell R, Trye P, Cottrell J, Mann SG, et al. Famotidine for healing and maintenance in nonsteroidal antiinflammatory drug-associated gastroduodenal ulceration. Gastroenterology 1997;112:1817-22.
35. Ciacci C, Zarrilli R, Ricci V, De Luca A, Mazzacca G, Del Vecchio Blanco C, et al. Histamine H2-receptor antagonist stimulate proliferation but not migration of human gastric mucosal cells in vitro. Dig Dis Sci 1996;41:972-8.
36. Alekseenko SA, Timoshin SS. The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer. Ter Arkh 1999;71:23-6.
37. Hahm KB, Park IS, Kim HC, Lee KJ, Kim JH, Cho SW, et al. Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine and famotidine, in gastric cancer cells. Int J Immunopharmacol 1996;18:393-9.
38. Hnatyszyn A. Comparison of the effectiveness of anti-ulcer drugs and their influence on angiogenesis in healing of experimental chronic gastric ulcer. Ann Acad Med Stetin 1995;41:183-91.
39. Szabo S, Sakoulas G, Kusstatsher S. Effects of endogenous and exogenous basic fibroblast growth factor in ulcer healing. Eur J Gastroenterol Hepatol 1993;5(Suppl 3):S53-7.
40. Tsuji S, Kawano S, Higashi T, Mukuda T, Imaizumi T, Tatsumi T, et al. Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine. J Clin Gastroenterol 1995;20(Suppl 2):S1-4.
41. Nakamura M, Oda M, Akiba Y, Inoue J, Ito T, Tsuchiya M, et al. Increased immunoreactivity and concentration of basic fibroblast growth factor in lansoprazole-treated gastric mucosa. J Clin Gastroenterol 1995;21(Suppl 1):S24-9.